Today in Medicine
SEE OTHER BRANDS

Fresh medicine news from the world

Press Releases

Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Today in Medicine.

Rocket Pharmaceuticals, Inc. (RCKT) Faces Securities Class Action Amid Protocol Change and FDA’s Clinical Hold on Gene Therapy Trial – Hagens Berman

Rocket Pharmaceuticals, Inc. (RCKT) Faces Securities Class Action Amid Protocol Change and FDA’s Clinical Hold on Gene Therapy Trial – Hagens Berman

SAN FRANCISCO, July 09, 2025 (GLOBE NEWSWIRE) -- A securities class action lawsuit styled Ho v. Rocket Pharmaceuticals, Inc., et al., No. 3:25-cv-10049 (D. N.J.) has been filed and seeks to represent investors who purchased or otherwise acquired...

Idaho Bureau of Emergency Medical Services joins Idaho Military Division

Idaho Bureau of Emergency Medical Services joins Idaho Military Division

Posted on Jul 9, 2025 | updated: Jul 9, 2025 The Idaho Military Division is excited to welcome the state’s Bureau of Emergency Medical Services into the organization. This transition, effective July 1, 2025, marks a significant step toward...

Idaho Bureau of Emergency Medical Services joins Idaho Military Division

Idaho Bureau of Emergency Medical Services joins Idaho Military Division

Posted on Jul 9, 2025 | updated: Jul 9, 2025 The Idaho Military Division is excited to welcome the state’s Bureau of Emergency Medical Services into the organization. This transition, effective July 1, 2025, marks a significant step toward...

Tonix Pharmaceuticals Announces On-line Publication of Phase 3 RESILIENT Trial Results of TNX-102 SL for Fibromyalgia in the Peer Reviewed Journal, Pain Medicine

Tonix Pharmaceuticals Announces On-line Publication of Phase 3 RESILIENT Trial Results of TNX-102 SL for Fibromyalgia in the Peer Reviewed Journal, Pain Medicine

The previously disclosed and now published RESILIENT data show that once-nightly TNX-102 SL achieved statistically significant improvement in the primary endpoint of reducing fibromyalgia pain versus placebo, and was generally well tolerated These...

Global Medical Device Cleaning Market is Expected to Showcase a Significant Growth at a CAGR of ~7% by 2032 | DelveInsight

Global Medical Device Cleaning Market is Expected to Showcase a Significant Growth at a CAGR of ~7% by 2032 | DelveInsight

New York, USA, July 09, 2025 (GLOBE NEWSWIRE) -- Global Medical Device Cleaning Market is Expected to Showcase a Significant Growth at a CAGR of ~7% by 2032 | DelveInsight The medical device cleaning market is witnessing steady growth, driven by...

HNL Lab Medicine Named Empowering Women Award Recipient for 2025

HNL Lab Medicine Named Empowering Women Award Recipient for 2025

ALLENTOWN, Pa., July 09, 2025 (GLOBE NEWSWIRE) -- HNL Lab Medicine has been named a recipient of the 2025 Empowering Women Award by Lehigh Valley Business and Central Penn Business Journal, in recognition of its strong commitment to advancing...

MISSD Launches National Campaign to Prevent Medication-Induced Harm

MISSD Launches National Campaign to Prevent Medication-Induced Harm

50 States, 5 Years, 1 Mission: Raise Akathisia Awareness to Save Lives SIOUX FALLS, SD, UNITED STATES, July 9, 2025 /⁨EINPresswire.com⁩/ -- The Medication-Induced Suicide Prevention and Education Foundation in Memory of Stewart Dolin (MISSD)...

GRX Marketing Celebrates 15 Years of Trusted Pharmacy Marketing Solutions

GRX Marketing Celebrates 15 Years of Trusted Pharmacy Marketing Solutions

Trusted marketing agency marks milestone with ongoing innovation and dedication to independent pharmacy success. DES MOINES, IA, UNITED STATES, July 9, 2025 /⁨EINPresswire.com⁩/ -- GRX Marketing, a trusted leader in pharmacy marketing solutions,...

Pharmaceutical Logistics Market Grows at 5.1% Compound annual growth rate (CAGR) to Reach US$106.8 Billion by 2031

Pharmaceutical Logistics Market Grows at 5.1% Compound annual growth rate (CAGR) to Reach US$106.8 Billion by 2031

Growth in pharmaceutical sector and rise in demand for reverse logistics have boosted the growth of the global pharmaceutical logistics market. WILMINGTON, NEW CASTLE, DE, UNITED STATES, July 8, 2025 /⁨EINPresswire.com⁩/ -- As per the report...

New Report: Despite Leading in Medical Education, New York Ranks 49th in Hospital Access

New Report: Despite Leading in Medical Education, New York Ranks 49th in Hospital Access

A new study reveals that despite world-class medical schools, many states face a dire shortage of accessible hospitals and staff. LOS ANGELES, CA, UNITED STATES, July 9, 2025 /⁨EINPresswire.com⁩/ -- - New York ranks 49th nationally for hospital...

Blue Goat Cyber Leads Medical Device Cybersecurity Compliance as FDA Finalizes New Guidance

Blue Goat Cyber Leads Medical Device Cybersecurity Compliance as FDA Finalizes New Guidance

Blue Goat Cyber leads medical device cybersecurity compliance, helping manufacturers meet the FDA’s finalized cybersecurity guidance issued June 27, 2025. SCOTTSDALE, AZ, UNITED STATES, July 9, 2025 /⁨EINPresswire.com⁩/ -- On June 27, 2025, the...

Dr. Mark Hawass selected as Top Doctor of the Year in Regenerative and Functional Medicine by IAOTP

Dr. Mark Hawass selected as Top Doctor of the Year in Regenerative and Functional Medicine by IAOTP

Dr. Mark Hawass honored member of the International Association of Top Professionals (IAOTP) will be honored at their annual awards gala in Las Vegas NEW YORK, NY, UNITED STATES, July 9, 2025 /⁨EINPresswire.com⁩/ -- Dr. Mark Hawass, a highly...

Medical Supplierz Welcomes International Medical Equipment Buyers

Medical Supplierz Welcomes International Medical Equipment Buyers

KUWAIT, KUWAIT, July 8, 2025 /⁨EINPresswire.com⁩/ -- Medical Supplierz, a specialized B2B digital marketplace for healthcare procurement, has opened its platform to verified international medical equipment buyers as part of its ongoing effort to...

Clover Health Launches New Jersey Community Pharmacy Program in Partnership with IPC’s iCare+ Network

Clover Health Launches New Jersey Community Pharmacy Program in Partnership with IPC’s iCare+ Network

WILMINGTON, Del., July 09, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover Health”), a leading Medicare Advantage company committed to affordable, high-quality care, today announced the launch of a new...

Liability Questions Rise as Dog Park Injuries Lead to Medical Claims in Louisiana

Liability Questions Rise as Dog Park Injuries Lead to Medical Claims in Louisiana

OPELOUSAS, LA, UNITED STATES, July 9, 2025 /⁨EINPresswire.com⁩/ -- As dog parks grow in popularity across Louisiana, so do the questions surrounding liability when injuries occur. Whether it’s a bite from another person’s dog, a collision between...

Evoke Pharma Receives Notice of Allowance for U.S. Patent Application for GIMOTI Extending Orange Book listings to 2036

Evoke Pharma Receives Notice of Allowance for U.S. Patent Application for GIMOTI Extending Orange Book listings to 2036

SOLANA BEACH, Calif., July 09, 2025 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on GIMOTI® (metoclopramide) nasal...

Salarius Pharmaceuticals’ Seclidemstat Demonstrates Supporting Role in Inhibiting Validated Oncology Target LSD1 in Two Recently Published Studies

Salarius Pharmaceuticals’ Seclidemstat Demonstrates Supporting Role in Inhibiting Validated Oncology Target LSD1 in Two Recently Published Studies

Phase 1/2 clinical study evaluating seclidemstat in patients with MDS and CMML is progressing with updates expected later this year Company continues to advance its contemplated merger with Decoy Therapeutics HOUSTON, July 09, 2025 (GLOBE...

Helius Medical Technologies, Inc. Compliant with Nasdaq’s Continued Listing Requirements

Helius Medical Technologies, Inc. Compliant with Nasdaq’s Continued Listing Requirements

NEWTOWN, Pa., July 09, 2025 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq: HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits,...

Adial Pharmaceuticals Files PCT Patent Application to Protect Core Assets and Extend IP Exclusivity on Core Technology to at least 2045

Adial Pharmaceuticals Files PCT Patent Application to Protect Core Assets and Extend IP Exclusivity on Core Technology to at least 2045

GLEN ALLEN, Va., July 09, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and...

Revolution Medicines and Iambic Announce Technology and Research Collaboration Using Iambic’s AI Discovery Tools to Pursue New Drug Candidates

Revolution Medicines and Iambic Announce Technology and Research Collaboration Using Iambic’s AI Discovery Tools to Pursue New Drug Candidates

Custom-built model will be trained using Revolution Medicines’ proprietary data to discover novel drug candidates Iambic to receive up to $25 million through a combination of upfront and expected near-term performance-based milestone payments for...

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service